Literature DB >> 15706401

Disease-associated prion protein elicits immunoglobulin M responses in vivo.

Mourad Tayebi1, Perry Enever, Zahid Sattar, John Collinge, Simon Hawke.   

Abstract

Prion diseases such as Creutzfeldt-Jakob disease are believed to result from the misfolding of a widely expressed normal cellular prion protein, PrPc. The resulting disease-associated isoforms, PrP(Sc), have much higher beta-sheet content, are insoluble in detergents, and acquire relative resistance to proteases. Although known to be highly aggregated and to form amyloid fibrils, the molecular architecture of PrP9Sc) is poorly understood. To date, it has been impossible to elicit antibodies to native PrP(Sc) that are capable of recognizing PrP(Sc) without denaturation, even in Pm-P(o/o) mice that are intolerant of it. Here we demonstrate that antibodies for native PrPc and PrP(Sc) can be produced by immunization of Pm-P(o/o) mice with partially purified PrPc and PrP(Sc) adsorbed to immunomagnetic particles using high-affinity anti-PrP monoclonal antibodies (mAbs). Interestingly, the polyclonal response to PrP(Sc) was predominantly of the immunoglobulin M (IgM) isotype, unlike the immunoglobulin G (IgG) responses elicited by PrP(c) or by recombinant PrP adsorbed or not to immunomagnetic particles, presumably reflecting the polymeric structure of disease-associated prion protein. Although heat-denatured PrP(Sc) elicited more diverse antibodies with the revelation of C-terminal epitopes, remarkably, these were also predominantly IgM suggesting that the increasing immunogenicity, acquisition of protease sensitivity, and reduction in infectivity induced by heat are not associated with dissociation of the PrP molecules in the diseased-associated protein. Adsorbing native proteins to immunomagnetic particles may have general applicability for raising polyclonal or monoclonal antibodies to any native protein, without attempting laborious purification steps that might affect protein conformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15706401      PMCID: PMC1431372          DOI: 10.2119/2004-00027.Tayebi

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  48 in total

1.  Scrapie surveillance in Great Britain: results of an abattoir survey, 1997/98.

Authors:  M M Simmons; S J Ryder; M C Chaplin; Y I Spencer; C R Webb; L J Hoinville; J Ryan; M J Stack; G A Wells; J W Wilesmith
Journal:  Vet Rec       Date:  2000-04-01       Impact factor: 2.695

2.  Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie.

Authors:  N A Mabbott; F Mackay; F Minns; M E Bruce
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

3.  Plasminogen binds to disease-associated prion protein of multiple species.

Authors:  M Maissen; C Roeckl; M Glatzel; W Goldmann; A Aguzzi
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

4.  A prion protein epitope selective for the pathologically misfolded conformation.

Authors:  Eustache Paramithiotis; Marc Pinard; Trebor Lawton; Sylvie LaBoissiere; Valerie L Leathers; Wen-Quan Zou; Lisa A Estey; Julie Lamontagne; Marty T Lehto; Leslie H Kondejewski; Gregory P Francoeur; Maria Papadopoulos; Ashkan Haghighat; Stephen J Spatz; Mark Head; Robert Will; James Ironside; Katherine O'Rourke; Quentin Tonelli; Harry C Ledebur; Avi Chakrabartty; Neil R Cashman
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

5.  Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue.

Authors:  K I O'Rourke; T V Baszler; T E Besser; J M Miller; R C Cutlip; G A Wells; S J Ryder; S M Parish; A N Hamir; N E Cockett; A Jenny; D P Knowles
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.

Authors:  C Soto; R J Kascsak; G P Saborío; P Aucouturier; T Wisniewski; F Prelli; R Kascsak; E Mendez; D A Harris; J Ironside; F Tagliavini; R I Carp; B Frangione
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

7.  Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy.

Authors:  S Krasemann; T Jürgens; W Bodemer
Journal:  J Biotechnol       Date:  1999-08-20       Impact factor: 3.307

Review 8.  T cell independent antigens.

Authors:  J J Mond; Q Vos; A Lees; C M Snapper
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

9.  Creutzfeldt-Jakob disease and cerebral amyloid angiopathy.

Authors:  F Gray; F Chrétien; P Cesaro; J Chatelain; P Beaudry; J L Laplanche; J Mikol; J Bell; P Gambetti; J D Degos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 10.  Molecular biology and genetics of prion diseases.

Authors:  S B Prusiner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1994-03-29       Impact factor: 6.237

View more
  5 in total

1.  A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines.

Authors:  Daryl Rhys Jones; William Alexander Taylor; Clive Bate; Monique David; Mourad Tayebi
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

2.  PrP antibody binding-induced epitope modulation evokes immunocooperativity.

Authors:  Binggong Chang; Michael W Miller; Marie S Bulgin; Sharon Sorenson-Melson; Aru Balachandran; Allen Chiu; Richard Rubenstein
Journal:  J Neuroimmunol       Date:  2008-10-31       Impact factor: 3.478

3.  Detection of retinal and blood Aβ oligomers with nanobodies.

Authors:  Umma Habiba; Joseph Descallar; Fabian Kreilaus; Utpal K Adhikari; Sachin Kumar; John W Morley; Bang V Bui; Maya Koronyo-Hamaoui; Mourad Tayebi
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-06

4.  PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.

Authors:  Mourad Tayebi; Daryl Rhys Jones; William Alexander Taylor; Benjamin Frederick Stileman; Charlotte Chapman; Deming Zhao; Monique David
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

5.  Experimental inoculation of CD11c+ B1 lymphocytes, CD68+ macrophages, or platelet-rich plasma from scrapie-infected sheep into susceptible sheep results in variable infectivity.

Authors:  Najiba Mammadova; Eric D Cassmann; S Jo Moore; Eric M Nicholson; Justin J Greenlee
Journal:  Access Microbiol       Date:  2020-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.